High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing's sarcoma family of tumours

Annals of Oncology

Volumn 17, Issue 8, 2006, Pages 1301-1305

  McTiernan, A ^a   Driver, D ^a   Michelagnoli, M P ^a   Kilby, A M ^a   Whelan, Jeremy S ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Ewing's sarcoma; High dose therapy; PNET

Indexed keywords

BUSULFAN; CARBOPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IFOSFAMIDE; MELPHALAN; PHOSPHATE; POTASSIUM; SODIUM; VINCRISTINE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ANEMIA; ARTICLE; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COLITIS; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; EDEMA; EVIDENCE BASED MEDICINE; EWING SARCOMA; FEMALE; GASTROINTESTINAL SYMPTOM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPERKALEMIA; HYPERNATREMIA; HYPOKALEMIA; HYPONATREMIA; HYPOPHOSPHATEMIA; INFECTION; LIVER DYSFUNCTION; LUNG ABSCESS; MALE; NAUSEA AND VOMITING; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; SCHOOL CHILD; STOMATITIS; THROMBOCYTOPENIA; VEIN OCCLUSION; WHOLE BODY RADIATION;

EID: 33747890191     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl108     Document Type: Article

References (26)

1. Ahrens S, Hoffmann C, Jabar S et al. Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: The CESS 86 experience. Cooperative Ewing Sarcoma Study. Med Pediatr Oncol 1999; 32: 186-195.
2. Paulussen M, Ahrens S, Dunst J et al. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol 2001; 19: 1818-1829.
3. Jurgens H, Exner U, Gadner H et al. Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial. Cancer 1988; 61: 23-32.
4. Cotterill SJ, Ahrens S, Paulussen M et al. Prognostic factors in Ewing's tumor of bone: Analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 2000; 18: 3108-3114.
5. ISRCTN Register. Database of randomised controlled trials with an International Standard Randomised Controlled Trial Number (ISRCTN), http://controlled-trials. com/isrctn/trial/I/0/61438620.html. Date accessed: 13.02.2006.
6. Rodriguez-Galindo C, Billups CA, Kun LE et al. Survival after recurrence of Ewing tumors: The St Jude Children's Research Hospital experience, 1979-1999. Cancer 2002; 94: 561-569.
7. Shankar AG, Ashley S, Craft AW, Pinkerton CR. Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma. Med Pediatr Oncol 2003; 40: 141-147.
8. Bacci G, Ferrari S, Longhi A et al. Therapy and survival after recurrence of Ewing's tumors: The Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997. Ann Oncol 2003; 14: 1654-1659.
9. Barker LM, Pendergrass TM, Sanders JE, Hawkins DS. Survival After Recurrence of Ewing's Sarcoma Family of Tumors. J Clin Oncol 2005; 23: 4354-4362.
10. Ladenstein R, Gadner H, Hartmann O et al. The European experience with megadose therapy and autologous bone marrow transplantation in solid tumors with poor prognosis (Ewing sarcoma, germ cell tumors and brain tumors). Wien Med Wochenschr 1995; 145: 55-57.
11. Burdach S, van Kaick B, Laws HJ et al. Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Dusseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria. Ann Oncol 2000; 11: 1451-1462.
12. Frohlich B, Ahrens S, Burdach S et al. High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma. (EI)CESS. Klin Padiatr 1999; 211: 284-290.
13. Ladenstein R, Lasset C, Pinkerton R et al. Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: A report from the EBMT Solid Tumour Registry. Bone Marrow Transplant 1995; 15: 697-705.
14. Whelan JS, McTiernan A, Kakouri E, Kilby A. Carboplatin-based chemotherapy for refractory and recurrent Ewing's tumours. Pediatr Blood Cancer 2004; 43: 237-242.
15. Burdach S, Meyer-Bahlburg A, Laws HJ et al. High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation. J Clin Oncol 2003; 21: 3072-3078.
16. Valteau-Couanet D, Oberlin O, Michon J et al. Treatment of metastatic Ewing's sarcomas with a strategy based on busulfan and melphalan high dose chemotherapy consolidation after conventional chemotherapy - a study of the French Society of Pediatric Oncology (SFOP). Acta Orthop Scand 1997; 68 (Suppl 277): S68 (abstr 27).
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
18. Cancer Therapy Evaluation Program. Common Toxicity Criteria, Version 2.0. DCTD, NCI, NIH, DHHS March, 1998.
19. Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995; 85: 3005-3020.
20. Paulussen M, Ahrens S, Burdach S et al. Primary metastatic (stage IV) Ewing tumor: Survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies. Ann Oncol 1998; 9: 275-281.
21. Horowitz ME, Kinsella TJ, Wexler LH et al. Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. J Clin Oncol 1993; 11: 1911-1918.
22. Meyers PA, Krailo MD, Ladanyi M et al, High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. J Clin Oncol 2001; 19: 2812-2820.
23. Prete A, Rondelli R, Dallorso S et al. Long-term overall survival and event free survival after high-dose chemotherapy and stem cell support in poor-prognosis Ewing's sarcoma of childhood. Bone Marrow Transplant 2005; 35 (suppl 2): S52 (abstract).
24. Gratwohl A, Baldomero H, Demirer T et al. Hematopoetic stem cell transplantation for solid tumors in Europe. Ann Oncol 2004; 15: 653-660.
25. Hawkins D, Barnett T, Bensinger W et al. Busulfan, melphalan, and thiotepa with or without total marrow irradiation with hematopoietic stem cell rescue for poor-risk Ewing-Sarcoma-Family tumors. Med Pediatr Oncol 2000; 34: 328-337.
26. Ladenstein R, Hartmann O, Pinkerton CR et al. A multivariate and matched pair analysis of high-risk Ewing tumor (ET) patients treated by megatherapy (MGT) and stem cell reinfusion (SCR) in Europe. Proc Am Soc Clin Oncol 1999; 18: 555 (abstract).